|
|
|
|
|
|
|
|
|
|
Rv2043c More about Rv2043c on TBDB.org More about Rv2043c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv2043c: Codons 60 to 64: 8 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Lemaitre N AAC 1999 | ACA/CCA | 181 | 61 | Thr/Pro | 1992 | France | Sequencing | Whole gene | ZHRES | 500ug/ml | - | 19/35 | 1/0 | - | - |
| Mestdagh M AAC 1999 | CCG/CAG?? | 185 | 62 | Pro/His | 1999 | Azerbaijan | Sequencing | Whole gene | Z | - | BACTEC 460 | 23/62 | 1/0 | - | - |
| Morlock GP AAC 2000 | CCG/CGG | 185 | 62 | Pro/Arg | 1999 | - | Sequencing | Whole gene | Z | >800 | Proportion method | 37/60 | 1/0 | - | - |
| Chan RCY JAC 2007 | CCG/CTG | 186 | 62 | Pro/Leu | 1994-2004 | Hong Kong | PCR-SSCP , Sequencing | Whole gene | Z | - | BACTEC MGIT 960 | 250 | 89 | - | - |
| Hirano K TLD 1997 | GAC/GGC | 188 | 63 | Asp/Gly | 1997 | Yemen | Sequencing | Whole gene | ZHRS | >800 | Proportion method | 33/168 | 1/0 | - | ![]() |
| Scorpio A Nature Med 1996 | GAC/CAC | 187 | 63 | Asp/His | - | USA (Colorado) | Sequencing | Whole gene | MDR | >500ug/ml | PZase test with Wayne's method | 39910 | 1/0 | - | - |
| Lee KW J Korean Med Sci 2001 | TAT/GAT | 190 | 64 | Tyr/Asp | 2001 | South korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 1/0 | - | - |
| Lemaitre N AAC 1999 | ins A | 192 | 64 | Frameshift | 1996 | France | Sequencing | Whole gene | ZSHE | 1000ug/ml | - | - | 1/0 | - | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |